June, 2018 | Gubra

JDRF and Gubra join forces to develop a new glucose responsive insulin for diabetes

Press Release New York and Hørsholm, Denmark, 18 June 2018 JDRF and Gubra today announced a partnership to develop a glucose-responsive insulin (GRI) as a treatment for people with insulin-requiring diabetes, such as type 1 diabetes (T1D). The Gubra approach is based...

JDRF and Gubra join forces to develop a new glucose responsive insulin for diabetes

Recent Posts

Recent Comments

Archives

Categories

Meta